Why Antibiotics cannot be the Main Treatment for Acute Pneumonia
Article Sidebar
Main Article Content
Abstract
Abstract
It has been known for almost two millennia that the inflammatory process of an organ disrupts its function, which determines the specificity of the clinical picture of the disease. Antibiotics can only have a selective antimicrobial effect but do not directly affect the mechanisms of the inflammatory process. The ability to suppress one of the initial factors of inflammation creates more favorable conditions for the body to fight inflammation. The first successes of antibiotics created the illusion of their decisive role in the treatment of inflammatory processes. Over time, under the influence of antibiotics, the etiology of pneumonia changed, and pathogens that are not included in the spectrum of action of antimicrobial drugs became leaders. This situation already now determines the urgent need for an urgent radical revision of the strategy in the treatment of pneumonia.
Downloads
Article Details
Copyright (c) 2025 Klepikov I.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Feigin R. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: W. B. Saunders; 2004;299. ISBN 978-0-7216-9329-3.
Podolsky SH. The changing fate of pneumonia as a public health concern in 20th-century America and beyond. Am J Public Health. 2005 Dec;95(12):2144-54. Available from: https://doi.org/10.2105/ajph.2004.048397
Waksman SA. What is an antibiotic or an antibiotic substance? Mycologia. 1947;39(5):565-569. Available from: https://pubmed.ncbi.nlm.nih.gov/20264541/
Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Rev Infect Dis. 1988;10(4):677–8. Available from: https://pubmed.ncbi.nlm.nih.gov/3055168/
Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Exp Biol Med. 1942;51:386–9. Available from: https://doi.org/10.3181/00379727-51-13986
Luria SE, Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 1943 Nov;28(6):491–511. Available from: https://doi.org/10.1093/genetics/28.6.491
Fleming A. The Nobel Prize in Physiology or Medicine 1945 - Penicillin: Nobel Lecture. NobelPrize.org. 1945. Available from: https://www.nobelprize.org/prizes/medicine/1945/fleming/lecture/
Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 2010;1:134. Available from: https://doi.org/10.3389/fmicb.2010.00134
Charles D. Despite pledges to cut back, farms are still using antibiotics. NPR. 2016 Dec 22. Available from: https://www.npr.org/sections/health-shots/2016/12/22/506282279/despite-pledges-to-cut-back-farms-are-still-using-antibiotics
Couce A, Blazquez J. Side effects of antibiotics on genetic variability. FEMS Microbiol Rev. 2009;33:531–8. Available from: https://doi.org/10.1111/j.1574-6976.2009.00165.x
Blázquez J, Couce A, Rodríguez-Beltrán J, Rodríguez-Rojas A. Antimicrobials as promoters of genetic variation. Curr Opin Microbiol. 2012;15:561–9. Available from: https://doi.org/10.1016/j.mib.2012.07.007
Larson E. Community factors in the development of antibiotic resistance. Annu Rev Public Health. 2007;28:435–47. Available from: https://doi.org/10.1146/annurev.publhealth.28.021406.144020
Enzler MJ, Berbari E, Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc. 2011 Jul;86(7):686–701. Available from: https://doi.org/10.4065/mcp.2011.0012
Alsaeed OM, Bukhari AA, Alshehri AA, Alsumairi FA, Alnami AM, Elsheikh HA. The use of antibiotics for the prevention of surgical site infections in two government hospitals in Taif, Saudi Arabia: A retrospective study. Cureus. 2022 Jul 11;14(7):e26731. Available from: https://doi.org/10.7759/cureus.26731
Heneghan C, Plueddemann A, Mahtani KR. Differentiating viral from bacterial pneumonia. The Centre for Evidence-Based Medicine. 2020 Apr 8. Available from: https://www.cebm.net/covid-19/differentiating-viral-from-bacterial-pneumonia
Kamat IS, Ramachandran V, Eswaran H, Guffey D, Master DM. Procalcitonin to distinguish viral from bacterial pneumonia: A systematic review and meta-analysis. Clin Infect Dis. 2020 Jan 16;70(3):538–42. Available from: https://doi.org/10.1093/cid/ciz545
Lhommet C, Garot D, Grammatico-Guillon L, Jourdannaud C, Asfar P, Faisy C, et al. Predicting the microbial cause of community-acquired pneumonia: Can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation? BMC Pulm Med. 2020;20:62. Available from: https://doi.org/10.1186/s12890-020-1089-y
Klepikov I. What does shortness of breath mean in acute pneumonia? Ameri J Clin Med Re. 2023:1–6. Available from: https://www.cmjpublishers.com/wp-content/uploads/2023/05/What-Does-Shortness-of-Breath-Mean-in-Acute-Pneumonia.pdf
Klepikov I. Myths, legends and real facts about acute lung inflammation. Cambridge Scholars Publishing. 2024;338. Available from: https://www.cambridgescholars.com/resources/pdfs/978-1-0364-0293-8-sample.pdf
Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: Don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020 Apr 29;26(7):808–10. Available from: https://doi.org/10.1016/j.cmi.2020.04.024
Beovic B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020; dkaa326. Available from: https://doi.org/10.1093/jac/dkaa326
Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing [published online ahead of print, 2020 May 2]. Clin Infect Dis. 2020;ciaa530. Available from: https://doi.org/10.1093/cid/ciaa530
World Health Organization. Antimicrobial resistance. 17 November 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Leiter RE. Reentry. N Engl J Med. 2020 Oct 14. Available from: https://www.nejm.org/doi/full/10.1056/NEJMp2027447
Rosenquist JN. The stress of Bayesian medicine — uncomfortable uncertainty in the face of COVID-19. N Engl J Med. 2021;384:7–9. Available from: https://doi.org/10.1056/nejmp2018857
Salisbury H. What might we learn from the covid-19 pandemic? BMJ. 2020;368:m1087. Available from: https://doi.org/10.1136/bmj.m1087
Oliver D. Conveyor belt medicine. BMJ. 2020;368:m162. Available from: https://pubmed.ncbi.nlm.nih.gov/32001451/
Millar MR, Walsh TR, Linton CJ, Zhang S, Leeming JP, Bennett PM, for the Alspac Study Team. Carriage of antibiotic-resistant bacteria by healthy children. J Antimicrob Chemother. 2001;47(5):605–10. Available from: https://doi.org/10.1093/jac/47.5.605
Centers for Disease Control and Prevention (CDC). Saving Lives. Protecting People. Methicillin-resistant Staphylococcus aureus (MRSA). Healthcare Settings. 2023. Available from: https://www.cdc.gov/mrsa/
Albrich WC, Harbarth S. Health-care workers: Source, vector, or victim of MRSA? Lancet Infect Dis. 2008;8:289–301. Available from: https://doi.org/10.1016/s1473-3099(08)70097-5
Aubry-Damon H, Grenet K, Ndiaye-Sall P, Che D, Corderio E, Bougnoux M, Rigaud E, Le Strat Y, Lemanissier V, Andremont A, et al. Antimicrobial resistance in commensal flora of pig farmers. Emerg Infect Dis. 2004;10:873–9. Available from: https://doi.org/10.3201/eid1005.030735
Graveland H, Wagenaar JA, Heesterbeek H, Mevius D, van Duijkeren E, Heederik D. Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: Human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS ONE. 2010;5:e10990. Available from: https://doi.org/10.1371/journal.pone.0010990
Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: A systematic review. Pneumonia. 2020;12:11. Available from: https://doi.org/10.1186/s41479-020-00074-3
Palomeque A, Cilloniz C, Soler-Comas A, Canseco-Ribas J, Rovira-Ribalta N, Motos A, et al. A review of the value of point-of-care testing for community-acquired pneumonia. Expert Rev Mol Diagn. 2024;1–14. Available from: https://doi.org/10.1080/14737159.2024.2391027
Li L, Ma J, Yu Z, Li M, Zhang W, Sun H. Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: An updated review. Microbiol Res. 2023;266:127221. Available from: https://doi.org/10.1016/j.micres.2022.127221
University of Liverpool. Tackling antibiotic resistance when treating pneumonia. ScienceDaily. 2024 Jan 18. Available from: https://www.sciencedaily.com/releases/2024/01/240118122140.htm
Kim K, Jung S, Kim M, Park S, Yang H, Lee E. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: A systematic review and meta-analysis. JAMA Netw Open. 2022;5(7):e2220949. Available from: https://doi.org/10.1001/jamanetworkopen.2022.20949
Cilloniz C, Dominedo C, Magdaleno D, Ferrer M, Gabarrús A, Torres A. Pure viral sepsis secondary to community-acquired pneumonia in adults: Risk and prognostic factors. J Infect Dis. 2019;220:1166–71. Available from: https://doi.org/10.1093/infdis/jiz257
Ponnuthurai B, A.K. A, Padmamabhan A, Arjun R. Etiological and clinical profile of virus-associated community-acquired pneumonia in adults. Chest Infections. 2020;157(6 Suppl):A55. Available from: https://doi.org/10.1016/j.chest.2020.05.063
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22. Available from: https://doi.org/10.1016/s0140-6736(20)30925-9
Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG, et al. Pneumonia. Nat Rev Dis Primers. 2021;7:25. Available from: https://www.nature.com/articles/s41572-021-00259-0
Rohani R, Yarnold PR, Scheetz MH, Neely MN, Kang M, et al. Individual Meropenem epithelial lining fluid and plasma PK/PD target attainment in patients with pneumonia. Open Forum Infect Dis. 2023;10(Supplement_2):ofad500.2177. Available from: https://doi.org/10.1093/ofid/ofad500.2177
Gu X, Zhou F, Wang Y, Fan G, Cao B. Respiratory viral sepsis: Epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020;29(157):200038. Available from: https://doi.org/10.1183/16000617.0038-2020
Lin CK, Tsai YH, Kao KC, Lin CM, Zhou SK, Ho MC, et al. Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: A prospective observational study. Eur J Med Res. 2023;28:155. Available from: https://doi.org/10.1186/s40001-023-01119-1
Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis, current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–72. Available from: https://doi.org/10.1164/rccm.201504-0781oc
Burkhart M. Improving sepsis bundle compliance in the emergency department. The Eleanor Mann School of Nursing Student Works. 2021. Available from: https://scholarworks.uark.edu/nursstudent/14
WHO. Sepsis. 2024. Available from: https://www.who.int/health-topics/sepsis#tab=tab_1
Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med. 2001;163(7):2011-8. Available from: https://doi.org/10.1164/ajrccm.163.7.2011088
Morgan AJ, Glossop AJ. Severe community-acquired pneumonia. BJA Education. 2016;16(5):167–72. Available from: https://doi.org/10.1093/bjaed/mkv052
Richards G, Levy H, Laterre PF, Feldman C, Woodward B, Bates BM, et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community-acquired pneumonia in PROWESS. J Intensive Care Med. 2011 Jan-Feb;26(1):34–40. Available from: https://doi.org/10.1177/0885066610383949
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. Available from: https://doi.org/10.1001/jama.2016.0287
Aliberti S, Brambilla AM, Chalmers JD, Cilloniz C, Ramirez J, Bignamini A, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res. 2014;15:27. Available from: https://doi.org/10.1186/1465-9921-15-27
Gattinoni L, Gattarello S, Steinberg I, Busana M, Palermo P, Lazzari S, et al. COVID-19 pneumonia: Pathophysiology and management. Eur Respir Rev. 2021;30:210138. Available from: https://doi.org/10.1183/16000617.0138-2021
Rollas K, Ersan G, Zincircioğlu C, Sahar I, Çalişkan T, Köse Güldogan I, et al. Septic shock in patients admitted to intensive care unit with COVID-19 pneumonia. Eurasian J Pulmonol. 2021;23:95-100. Available from: https://eurasianjpulmonol.com/storage/upload/pdfs/1639396765-en.pdf